Capsida Biotherapeutics Inc., a biotechnology company developing targeted gene therapies using its next-generation adeno-associated virus (AAV) engineering platform, has appointed Swati Tole, M.D., as chief medical officer. Dr. Tole brings extensive drug development experience including senior-level leadership positions in the biotech industry across a wide spectrum of disease areas in adults and children including rheumatology, gastroenterology, hepatology, and infectious diseases.    “...